Brief Communicationposted 2024-08-28 01:48:12
Assessing CD36 and CD47 expression levels in solid tumor indications to stratify patients for VT1021 treatment
SUMING WANG, Victor Zota, Melanie Vincent, Donna Clossey, Jian Chen, Michael Cieslewicz, Randolph Watnick, and 2 more authors
Under Review
at
Articleposted 2024-08-26 18:00:38
Synergistic and antagonistic drug interactions are prevalent but not conserved across acute myeloid leukemia cell lines
Erdal Toprak, Fatma Neslihan Kalkan, M. Yildiz, N. Ezgi Wood, Michael Farid, Melissa McCoy, Milo Lin, and 3 more authors
Posted
at
Articleposted 2024-07-23 12:52:51
Maximizing the clinical utility and performance of cytology samples for comprehensive genetic profiling – A report on the impact of process optimization through the analysis of 4,871 cytology samples profiled by MSK-IMPACT
David Kim, Chad Vanderbilt, Soo-Ryum Yang, Subhiksha Nandakumar, Khedoudja Nafa, Rusmir Feratovic, Natasha Rekhtman, and 8 more authors
Under Review
at
Articleposted 2024-03-18 17:14:29
Single-cell RNA sequencing combined with mendelian randomization analysis identifies putatively causal genes associated with Gastric cancer
Yuan Xu, Li-hua Jia, Wei-ming Yu, Mian Yang
Posted
at
Articleposted 2024-02-06 06:39:22
Synthesis and new DNA targeting activity of 6- and 7-tert-butylfascaplysins
Sergey A. Dyshlovoy, Wael Y. Mansour, Natalia A. Ramm, Jessica Hauschild, Maxim E. Zhidkov, Malte Kriegs, Alexandra Zielinski, and 9 more authors
Under Review
at
Articleposted 2024-01-31 17:52:54
Safety and efficacy of anlotinib-based regimen in patients with unresectable or metastatic bone and soft-tissue sarcomas: a retrospective institutional study
Lina Pang, Shengli Zhang, Liye Wang, Shuai Gong, Xiaoke Zhang, Wei He
Posted
at
Articleposted 2023-12-02 01:53:36
Fe3O4@Chitosan@ZIF-8@RVG29, an Anti-Glioma Nanoplatform Guided By Fixed and Activated By Alternating Magnetic Field
Mohammad-Nabil Savari
Published
at
Articleposted 2023-10-11 01:44:19
Identification of potentially actionable genetic variants in epithelial ovarian cancer: A retrospective cohort study
Kathleen Claes, Charlotte Fieuws, Joni Van der Meulen, Kristiaan Proesmans, Emiel De Jaeghere, Siebe Loontiens, Jo Van Dorpe, and 3 more authors
Published
at
Articleposted 2023-08-11 13:59:47
Comparative overall survival of CKD4/6 inhibitors in combination with endocrine therapy in advanced breast cancer
Coralea Kappel, Mitchell Elliott, Vikaash Kumar, Michelle Nadler, Alexandra Desnoyer, Eitan Amir
Published
at
Articleposted 2023-07-07 13:39:41
Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study
Simona Pisegna, Simone Scagnoli, Angela Toss, Roberta Caputo, Michelino De Laurentiis, Michela Palleschi, Ugo De Giorgi, and 25 more authors
Published
at
